Illumina Body Map 2 (GSE30611)
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.5 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 1.4 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.1 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 1.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.7 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
0.1 | 0.7 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.6 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.0 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.4 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 0.1 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.0 | 0.0 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.8 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | NABA COLLAGENS | Genes encoding collagen proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |